Home
Target List
Selection
Community Requests
Clones
XML files
Diffraction Images
Progress
Homolog Search
Clustering
Statistics
News
Help
Log In
Consortium
Overview
Investigators
Experiments
X-ray Structures
NMR Structures
Electronic Structure Description
Publications
Resources
Clustering
Related Sites
Progress
Collaborators
Basecamp
Contact Us
Log In
Targets
Filter Targets:
Selection Phase:
No Filter
Community Requests
January 2009
Phase 1: October 2007
Phase 2: March 2008
Phase 3: June 2008
Phase 4: April 2009
Phase 5: 2010
Tigr Main Category:
No Filter
0
Actin tail formation
Amino acid biosynthesis
Amino acid biosynthesis: Aromatic amino acid family
Amino acid biosynthesis: Aspartate family
Amino acid biosynthesisBiosynthesis of cofactors, prosthetic groups, and carriers
Amino acid biosynthesisBiosynthesis of cofactors, prosthetic groups, and carriers,
Amino acid biosynthesisBiosynthesis of cofactors, prosthetic groups, and carriers,Purines, pyrimidin
Amino acid biosynthesisCell envelope,
Amino acid biosynthesisCentral intermediary metabolism
Amino acid biosynthesisCentral intermediary metabolism,
Amino acid biosynthesisCentral intermediary metabolism,Purines, pyrimidines, nucleosides, and nucleo
Amino acid biosynthesisEnergy metabolism,
Amino acid biosynthesisFatty acid and phospholipid metabolism
Amino acid biosynthesisFatty acid and phospholipid metabolism,
Amino acid biosynthesisRegulatory functions
Amino acid biosynthesisRegulatory functions,
Amino acid biosynthesis: Serine family
Biosynthesis of cofactors, prosthetic groups, and carriers
Biosynthesis of cofactors, prosthetic groups, and carriersCell envelope,
Biosynthesis of cofactors, prosthetic groups, and carriersCentral intermediary metabolism
Biosynthesis of cofactors, prosthetic groups, and carriersCentral intermediary metabolism,
Biosynthesis of cofactors, prosthetic groups, and carriersCentral intermediary metabolism,Protein sy
Biosynthesis of cofactors, prosthetic groups, and carriers: Glutathione and analogs
Biosynthesis of cofactors, prosthetic groups, and carriers: Heme, porphyrin, and cobalamin
Biosynthesis of cofactors, prosthetic groups, and carriers: Menaquinone and ubiquinone
Biosynthesis of cofactors, prosthetic groups, and carriers: Other
Biosynthesis of cofactors, prosthetic groups, and carriersPurines, pyrimidines, nucleosides, and nuc
Biosynthesis of cofactors, prosthetic groups, and carriers: Pyridine nucleotides
Biosynthesis of cofactors, prosthetic groups, and carriersRegulatory functions,
Biosynthesis of cofactors, prosthetic groups, and carriers: Riboflavin, FMN, and FAD
Biosynthesis of cofactors, prosthetic groups, and carriers: Thiamine
Cell envelope
Cell envelope: Biosynthesis and degradation of murein sacculus and peptidoglycan
Cell envelope: Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides
Cell envelopeCellular processes
Cell envelopeCellular processes,
Cell envelopeEnergy metabolism,
Cell envelopeFatty acid and phospholipid metabolism,
Cell envelopeMobile and extrachromosomal element functions
Cell envelopeMobile and extrachromosomal element functions,
Cell envelope: Other
Cell envelopeProtein fate
Cell envelopeProtein fate,
Cell envelopeRegulatory functions,Unknown function
Cell envelopeRegulatory functions,Unknown function,
Cell envelope: Surface structures
Cell envelopeTransport and binding proteins,
Cell envelopeTransport and binding proteins,Cellular processes,
Cell envelopeUnclassified,
Cell envelopeUnknown function
Cell envelopeUnknown function,
Cellular processes
Cellular processes: Adaptations to atypical conditions
Cellular processes: Cell adhesion
Cellular processes: Cell division
Cellular processesCentral intermediary metabolism,Signal transduction,
Cellular processes: Chemotaxis and motility
Cellular processes: Detoxification
Cellular processes: DNA transformation
Cellular processesEnergy metabolism,
Cellular processesEnergy metabolism,Protein fate,
Cellular processes: Other
Cellular processes: Pathogenesis
Cellular processesProtein synthesis
Cellular processesProtein synthesis,
Cellular processesRegulatory functions
Cellular processesRegulatory functions,
Cellular processes: Sporulation and germination
Cellular processes: Toxin production and resistance
Cellular processesTranscription
Cellular processesTranscription,
Cellular processesTransport and binding proteins
Cellular processesTransport and binding proteins,
Central intermediary metabolism
Central intermediary metabolism: Amino sugars
Central intermediary metabolismEnergy metabolism,
Central intermediary metabolismEnergy metabolism,Fatty acid and phospholipid metabolism,
Central intermediary metabolismEnergy metabolism,Unknown function,
Central intermediary metabolism: Nitrogen metabolism
Central intermediary metabolism: Other
Central intermediary metabolismProtein fate,
Central intermediary metabolismPurines, pyrimidines, nucleosides, and nucleotides,
Central intermediary metabolismUnknown function
Central intermediary metabolismUnknown function,
Chr.
conserved hypothetical proteins
Conserved Hypothetical proteins
Disrupted reading frame
DNA metabolism
DNA metabolism: Degradation of DNA
DNA metabolism: DNA replication, recombination, and repair
DNA metabolismMobile and extrachromosomal element functions,
DNA metabolismTranscription,
Energy metabolism
Energy metabolism: ATP-proton motive force interconversion
Energy metabolism: Biosynthesis and degradation of polysaccharides
Energy metabolism: Electron transport
Energy metabolismFatty acid and phospholipid metabolism
Energy metabolismFatty acid and phospholipid metabolism,
Energy metabolism: Fermentation
Energy metabolism: Glycolysis/gluconeogenesis
Energy metabolismPurines, pyrimidines, nucleosides, and nucleotides,
Energy metabolismRegulatory functions,Protein synthesis
Energy metabolismRegulatory functions,Protein synthesis,
Energy metabolism: Sugars
Energy metabolism: TCA cycle
Energy metabolismTransport and binding proteins,
Energy metabolismTransport and binding proteins,Central intermediary metabolism,
Energy metabolismUnknown function,
Entry and Cell-Cell Fusion
Fatty acid and phospholipid metabolism
Fatty acid and phospholipid metabolism: Biosynthesis
Fatty acid and phospholipid metabolism: Degradation
host defense modulator
host-range
host-range, binds EGF receptor
host-range determinant, host defense modulator
host range factor
host range factor, host defense modulator
host range, host defense modulator, prevents syncytia
host-range, possible host defense modulator
host range protein
Hypothetical proteins
Hypothetical proteins: Conserved
Hypothetical proteins: Domain
in virion, inactive
Mobile and extrachromosomal element functions
Mobile and extrachromosomal element functions: Other
Mobile and extrachromosomal element functions: Plasmid functions
Mobile and extrachromosomal element functions: Prophage functions
#N/A
N/A
No Data
Protein fate
Protein fateCellular processes,
Protein fate: Degradation of proteins, peptides, and glycopeptides
Protein fateEnergy metabolism,DNA metabolism,
Protein fate: Protein and peptide secretion and trafficking
Protein fate: Protein folding and stabilization
Protein fate: Protein modification and repair
Protein fateRegulatory functions
Protein fateRegulatory functions,
Protein synthesis
Protein synthesis: Ribosomal proteins: synthesis and modification
Protein synthesis: tRNA aminoacylation
Protein synthesis: tRNA and rRNA base modification
Purines, pyrimidines, nucleosides, and nucleotides
Purines, pyrimidines, nucleosides, and nucleotidesEnergy metabolism,
Purines, pyrimidines, nucleosides, and nucleotides: Nucleotide and nucleoside interconversions
Purines, pyrimidines, nucleosides, and nucleotides: Other
Purines, pyrimidines, nucleosides, and nucleotidesProtein synthesis,
Purines, pyrimidines, nucleosides, and nucleotides: Pyrimidine ribonucleotide biosynthesis
Purines, pyrimidines, nucleosides, and nucleotides: Salvage of nucleosides and nucleotides
Purines, pyrimidines, nucleosides, and nucleotides: Sugar-nucleotide biosynthesis and conversions
Purines, pyrimidines, nucleosides, and nucleotidesTransport and binding proteins,
Regulatory functions
Regulatory functionsAmino acid biosynthesis
Regulatory functionsAmino acid biosynthesis,
Regulatory functions: DNA interactions
Regulatory functionsDNA metabolism,
Regulatory functions: Other
Regulatory functions: RNA interactions
Regulatory functionsSignal transduction
Regulatory functionsSignal transduction,
Regulatory functionsTransport and binding proteins,
Signal transduction
Signal transduction: PTS
S-S bond formation pathway
Transcription
Transcription: Degradation of RNA
TranscriptionUnknown function,
Transport and binding proteins
Transport and binding proteins: Amino acids, peptides and amines
Transport and binding proteins: Anions
Transport and binding proteinsBiosynthesis of cofactors, prosthetic groups, and carriers,
Transport and binding proteins: Carbohydrates, organic alcohols, and acids
Transport and binding proteins: Cations and iron carrying compounds
Transport and binding proteins: Nucleosides, purines and pyrimidines
Transport and binding proteins: Other
Transport and binding proteins: Unknown substrate
Unclassified
Unclassified: Role category not yet assigned
unknown
unknown, conserved protein
Unknown function
Unknown function: Enzymes of unknown specificity
Unknown function: General
Viral functions
Viral functions: General
Organism:
No Filter
Acinetobacter baumannii
Acinetobacter baumannii ATCC 17978
Acinetobacter baumannii SDF
Acinetobacter haemolyticus
Acinetobacter sp. ATCC 27244
Actinobacillus pleuropneumoniae serovar 5b str. L20
Agrobacterium tumefaciens str. C58
Aquifex aeolicus VF5
Bacillus anthracis str. Ames
Bacillus anthracis str. 'Ames Ancestor'
Bacillus anthracis str. Sterne
Bacillus subtilis
Bacillus subtilis subsp. subtilis str. 168
Bacteroides thetaiotaomicron VPI-5482
Bifidobacterium longum subsp. infantis ATCC 15697
Bordetella pertussis Tohama I
Borrelia burgdorferi B31
Burkholderia mallei ATCC 23344
Burkholderia pseudomallei K96243
Burkholderia pseudomallei MSHR346
Campylobacter jejuni subsp. jejuni NCTC 11168
Cell fusing agent virus
Chlamydia muridarum Nigg
Chlamydia trachomatis
Chlamydia trachomatis D/UW-3/CX
Clostridium difficile 630
Clostridium perfringens ATCC 13124
Cowpox virus
Cowpox virus (Brighton Red)
Coxiella burnetii RSA 493
Coxsackievirus B3 (strain Woodruff)
Dengue virus 1
Dengue virus 2
Dengue virus 3
Dengue virus 4
Ectromelia virus
Enterobacter cloacae
Enterococcus faecalis
Enterococcus faecalis V583
Enterococcus faecium
Enterococcus faecium DO
Enterococcus gallinarum
Escherichia coli
Escherichia coli 042
Escherichia coli CFT073
Escherichia coli ETEC H10407
Escherichia coli O103:H2 str. 12009
Escherichia coli O157:H7 str. EDL933
Escherichia coli O157:H7 str. Sakai
Escherichia coli str. K-12 substr. MG1655
Escherichia coli UTI89
Francisella novicida U112
Francisella tularensis subsp. holarctica LVS
Francisella tularensis subsp. tularensis SCHU S4
Haemophilus influenzae PittII
Helicobacter pylori
Helicobacter pylori 26695
Helicobacter pylori J99
Herpesvirus saimiri (strain 488)
Homo sapiens
Human echovirus 7
Human herpesvirus 6
Human herpesvirus 8
Human herpesvirus 8 type M
Influenza A virus (A/Aichi/2/1968(H3N2))
Influenza A virus (A/California/07/2009(H1N1))
Influenza A virus (A/Puerto Rico/8/1934(H1N1))
Influenza A virus (A/udorn/1972(H3N2))
Influenza B virus (B/Lee/40)
Japanese encephalitis virus
Legionella pneumophila 130b
Legionella pneumophila subsp. pneumophila str. Philadelphia 1
Listeria monocytogenes
Listeria monocytogenes EGD-e
Modoc virus
Monkeypox virus
Montana myotis leukoencephalitis virus
Murid herpesvirus 4
Murray Valley encephalitis virus
Mus musculus
Mycobacterium smegmatis str. MC2 155
Mycobacterium tuberculosis H37Rv
Myxoma virus (strain Lausanne)
Neisseria gonorrhoeae FA 1090
Proteus mirabilis
Providencia stuartii
Pseudomonas aeruginosa
Pseudomonas aeruginosa PAO1
Pseudomonas aeruginosa UCBPP-PA14
Pseudomonas fluorescens Pf-5
Pseudomonas putida KT2440
Rickettsia prowazekii str. Madrid E
Rio Bravo virus
Salmonella enterica subsp. enterica serovar Paratyphi A str. ATCC 9150
Salmonella enterica subsp. enterica serovar Typhimurium
Salmonella enterica subsp. enterica serovar Typhimurium str. LT2
SARS coronavirus
Shigella dysenteriae 1012
Shigella dysenteriae Sd197
Shigella flexneri
Shigella flexneri 2a str. 2457T
Shigella flexneri 2a str. 301
Staphylococcus aureus
Staphylococcus aureus subsp. aureus COL
Staphylococcus aureus subsp. aureus MRSA252
Staphylococcus aureus subsp. aureus Mu3
Staphylococcus aureus subsp. aureus Mu50
Staphylococcus aureus subsp. aureus N315
Staphylococcus aureus subsp. aureus NCTC 8325
Staphylococcus aureus subsp. aureus str. Newman
Staphylococcus aureus subsp. aureus USA300_TCH1516
Staphylococcus epidermidis
Staphylococcus epidermidis RP62A
Staphylococcus haemolyticus
St. Louis encephalitis virus (strain MS1-7)
Streptococcus agalactiae 2603V/R
Streptococcus agalactiae A909
Streptococcus agalactiae NEM316
Streptococcus bovis ATCC 700338
Streptococcus downei F0415
Streptococcus dysgalactiae subsp. equisimilis
Streptococcus dysgalactiae subsp. equisimilis GGS_124
Streptococcus equinus ATCC 9812
Streptococcus equi subsp. zooepidemicus
Streptococcus equi subsp. zooepidemicus MGCS10565
Streptococcus gallolyticus UCN34
Streptococcus infantarius subsp. infantarius ATCC BAA-102
Streptococcus mutans UA159
Streptococcus parauberis KCTC 11537
Streptococcus pneumoniae G54
Streptococcus pneumoniae Hungary19A-6
Streptococcus pneumoniae P1031
Streptococcus pneumoniae R6
Streptococcus pneumoniae str. Canada MDR_19A
Streptococcus pneumoniae str. Canada MDR_19F
Streptococcus pneumoniae TCH8431/19A
Streptococcus pneumoniae TIGR4
Streptococcus porcinus str. Jelinkova 176
Streptococcus pyogenes
Streptococcus pyogenes M1 GAS
Streptococcus pyogenes MGAS5005
Streptococcus pyogenes NZ131
Streptococcus pyogenes str. Manfredo
Streptococcus sp. 'group G'
Streptococcus suis P1/7
Streptococcus suis SC84
Streptococcus thermophilus LMD-9
Streptococcus thermophilus LMG 18311
Streptococcus uberis 0140J
Streptomyces fradiae
Streptomyces griseus
Streptomyces toyocaensis
synthetic construct
Toxoplasma gondii
Toxoplasma gondii GT1
Toxoplasma gondii ME49
Treponema pallidum subsp. pallidum str. Nichols
Vaccinia virus
Vaccinia virus Copenhagen
Vaccinia virus L-IPV
Vaccinia virus WR
Vibrio cholerae
Vibrio cholerae O1 biovar El Tor str. N16961
Vibrio cholerae O395
Vibrio fischeri ES114
Vibrio mimicus
Vibrio parahaemolyticus
Vibrio parahaemolyticus RIMD 2210633
Vibrio sp. AND4
Vibrio vulnificus CMCP6
Western equine encephalomyelitis virus
Yellow fever virus
Yersinia pestis CO92
Yersinia pestis KIM 10
Yersinia pseudotuberculosis IP 32953
Zaire ebolavirus
Species:
No Filter
Acinetobacter baumannii
Acinetobacter haemolyticus
Acinetobacter sp. ATCC 27244
Actinobacillus pleuropneumoniae
Agrobacterium tumefaciens
Aliivibrio fischeri
Aquifex aeolicus
Bacillus anthracis
Bacillus subtilis
Bacteroides thetaiotaomicron
Bifidobacterium longum
Bordetella pertussis
Borrelia burgdorferi
Burkholderia mallei
Burkholderia pseudomallei
Campylobacter jejuni
Cell fusing agent virus
Chlamydia muridarum
Chlamydia trachomatis
Clostridium difficile
Clostridium perfringens
Cowpox virus
Coxiella burnetii
Dengue virus
Ectromelia virus
Enterobacter cloacae
Enterococcus faecalis
Enterococcus faecium
Enterococcus gallinarum
Escherichia coli
Francisella novicida
Francisella tularensis
Haemophilus influenzae
Helicobacter pylori
Homo sapiens
Human enterovirus B
Human herpesvirus 6
Human herpesvirus 8
Influenza A virus
Influenza B virus
Japanese encephalitis virus
Legionella pneumophila
Listeria monocytogenes
Modoc virus
Monkeypox virus
Montana myotis leukoencephalitis virus
Murid herpesvirus 4
Murray Valley encephalitis virus
Mus musculus
Mycobacterium smegmatis
Mycobacterium tuberculosis
Myxoma virus
Neisseria gonorrhoeae
Proteus mirabilis
Providencia stuartii
Pseudomonas aeruginosa
Pseudomonas fluorescens
Pseudomonas putida
Rickettsia prowazekii
Rio Bravo virus
Saimiriine herpesvirus 2
Salmonella enterica
Severe acute respiratory syndrome-related coronavirus
Shigella dysenteriae
Shigella flexneri
Staphylococcus aureus
Staphylococcus epidermidis
Staphylococcus haemolyticus
St. Louis encephalitis virus
Streptococcus agalactiae
Streptococcus downei
Streptococcus dysgalactiae
Streptococcus equi
Streptococcus equinus
Streptococcus gallolyticus
Streptococcus infantarius
Streptococcus mutans
Streptococcus parauberis
Streptococcus pneumoniae
Streptococcus porcinus
Streptococcus pyogenes
Streptococcus sp. 'group G'
Streptococcus suis
Streptococcus thermophilus
Streptococcus uberis
Streptomyces fradiae
Streptomyces griseus
Streptomyces toyocaensis
synthetic construct
Toxoplasma gondii
Treponema pallidum
Vaccinia virus
Vibrio cholerae
Vibrio mimicus
Vibrio parahaemolyticus
Vibrio sp. AND4
Vibrio vulnificus
Western equine encephalomyelitis virus
Yellow fever virus
Yersinia pestis
Yersinia pseudotuberculosis
Zaire ebolavirus
Priority:
No Filter
0
1
6
8
Keyword:
Type Keyword
Stage:
No Filter
cloned
crystallized
crystal_structure
diffraction
expressed
in_pdb
purified
selected
soluble
work_stopped
Clone Location
No Filter
Argonne National Laboratory
Collaborators of the CSGID
J. Craig Venter Institute
Northwestern University
University of Toronto
University of Texas Southwestern Medical Center
University of Virginia
Washington University
Remove Filters
Download data as tab-separated value (TSV) file
(which can be used as a input for Microsoft Office Excel and Open Office Calc)
Jump to Target:
In
IDP#
NCBI GI
LOCUS TAG
Search
Page 18 of 60, showing 100 records out of 5960 total, starting on record 1701
previous
|
9
|
10
|
11
|
12
|
13
|
14
|
15
|
16
|
17
|
18
|
19
|
20
|
21
|
22
|
23
|
24
|
25
|
26
|
27
|
next
CSGID ID
Priority
stage
Locus Tag
NCBI GI
Gene
Name
Common Name
Sequence
Length
Justification
Selection
Phase
Homolog
PDB ID
Homolog
Sequence
Identity
Target Organism
TIGR Main Role
TIGR Subrole
Request Person
IDP05746
(
show subtarget assignments
)
1
cloned
CD3402
126701025
murB
UDP-N-acetylenolpyruvoylglucosamine redu...
317
essential/virulence/pathogenesis /
Targets showing phylogenetic evidence for essentiality, virulence or pathogenesi...
Phase 5: 2010
3TX1
43.1%
Clostridium difficile
Cell envelope: Biosynthesis and degradation of murein sacculus and peptidoglycan
IDP05742
(
show subtarget assignments
)
1
cloned
CD2655
126700269
murF
UDP-N-acetylmuramoyl-tripeptide--D-alany...
457
essential/virulence/pathogenesis /
Targets showing phylogenetic evidence for essentiality, virulence or pathogenesi...
Phase 5: 2010
1GG4
31.2%
Clostridium difficile
Cell envelope: Biosynthesis and degradation of murein sacculus and peptidoglycan
IDP05743
(
show subtarget assignments
)
1
cloned
CD2653
126700267
murD
UDP-N-acetylmuramoylalanine--D-glutamate...
451
essential/virulence/pathogenesis /
Targets showing phylogenetic evidence for essentiality, virulence or pathogenesi...
Phase 5: 2010
3LK7
38.9%
Clostridium difficile
Cell envelope: Biosynthesis and degradation of murein sacculus and peptidoglycan
IDP05097
(
show subtarget assignments
)
1
cloned
CD0226
126697797
putative transglycosylase [Clostridium d...
222
essential/virulence/pathogenesis /
Targets showing phylogenetic evidence for essentiality, virulence or pathogenesi...
Phase 5: 2010
Clostridium difficile
Cell envelope: Biosynthesis and degradation of murein sacculus and peptidoglycan
IDP05652
(
show subtarget assignments
)
1
cloned
lmo0129
16802177
-
hypothetical protein lmo0129 [Listeria m...
246
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
3NE8
27.2%
Listeria monocytogenes
Cell envelope: Biosynthesis and degradation of murein sacculus and peptidoglycan
IDP05079
(
show subtarget assignments
)
1
cloned
lmo1438
16803478
-
hypothetical protein lmo1438 [Listeria m...
721
potential drug target /
Known drug target or ortholog of known drug target
Phase 5: 2010
2WAE
32.6%
Listeria monocytogenes
Cell envelope: Biosynthesis and degradation of murein sacculus and peptidoglycan
IDP05624
(
show subtarget assignments
)
1
cloned
CD1146
126698741
mreC
putative rod shape-determining protein [...
297
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
2J5U
25.3%
Clostridium difficile
Cell envelope: Biosynthesis and degradation of murein sacculus and peptidoglycan
IDP05556
(
show subtarget assignments
)
1
cloned
lmo1521
16803561
-
hypothetical protein lmo1521 [Listeria m...
427
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
3NE8
17.1%
Listeria monocytogenes
Cell envelope: Biosynthesis and degradation of murein sacculus and peptidoglycan
IDP05542
(
show subtarget assignments
)
1
cloned
Cj0508
6967973
pbpA
hypothetical protein Cj0504c [Campylobac...
643
potential drug target /
Known drug target or ortholog of known drug target
Phase 5: 2010
3FWL
31.1%
Campylobacter jejuni
Cell envelope: Biosynthesis and degradation of murein sacculus and peptidoglycan
IDP05066
(
show subtarget assignments
)
1
cloned
CD2654
126700268
mraY
phospho-N-acetylmuramoyl-pentapeptide-tr...
321
essential/virulence/pathogenesis /
Targets showing phylogenetic evidence for essentiality, virulence or pathogenesi...
Phase 5: 2010
Clostridium difficile
Cell envelope: Biosynthesis and degradation of murein sacculus and peptidoglycan
IDP05067
(
show subtarget assignments
)
1
cloned
CD2664
126700278
murE
UDP-N-acetylmuramoylalanyl-D-glutamate--...
484
essential/virulence/pathogenesis /
Targets showing phylogenetic evidence for essentiality, virulence or pathogenesi...
Phase 5: 2010
2WTZ
36.2%
Clostridium difficile
Cell envelope: Biosynthesis and degradation of murein sacculus and peptidoglycan
IDP05529
(
show subtarget assignments
)
1
cloned
CD2658
126700272
mraW
S-adenosyl-methyltransferase [Clostridiu...
318
essential/virulence/pathogenesis /
Targets showing phylogenetic evidence for essentiality, virulence or pathogenesi...
Phase 5: 2010
1WG8
41.2%
Clostridium difficile
Cell envelope: Biosynthesis and degradation of murein sacculus and peptidoglycan
IDP05051
(
show subtarget assignments
)
1
cloned
CD0127
126697699
mreB1
rod shape-determining protein Mbl [Clost...
339
essential/virulence/pathogenesis /
Targets showing phylogenetic evidence for essentiality, virulence or pathogenesi...
Phase 5: 2010
1JCE
52.2%
Clostridium difficile
Cell envelope: Biosynthesis and degradation of murein sacculus and peptidoglycan
IDP05345
(
show subtarget assignments
)
1
soluble
Z3383
12516442
pbpG
penicillin-binding protein 7 [Escherichi...
313
potential drug target /
Known drug target or ortholog of known drug target
Phase 5: 2010
1XP4
25.9%
Escherichia coli
Cell envelope: Biosynthesis and degradation of murein sacculus and peptidoglycan
IDP05326
(
show subtarget assignments
)
1
cloned
CD3562
126701188
murI
glutamate racemase [Clostridium difficil...
268
essential/virulence/pathogenesis /
Targets showing phylogenetic evidence for essentiality, virulence or pathogenesi...
Phase 5: 2010
3OUT
45.2%
Clostridium difficile
Cell envelope: Biosynthesis and degradation of murein sacculus and peptidoglycan
IDP05022
(
show subtarget assignments
)
1
cloned
CD1145
126698740
mreB2
rod shape-determining protein MreB [Clos...
353
essential/virulence/pathogenesis /
Targets showing phylogenetic evidence for essentiality, virulence or pathogenesi...
Phase 5: 2010
1JCE
54.4%
Clostridium difficile
Cell envelope: Biosynthesis and degradation of murein sacculus and peptidoglycan
IDP05293
(
show subtarget assignments
)
1
cloned
CD1408
126699011
ddl
D-alanine--D-alanine ligase [Clostridium...
299
essential/virulence/pathogenesis /
Targets showing phylogenetic evidence for essentiality, virulence or pathogenesi...
Phase 5: 2010
3R23
51.5%
Clostridium difficile
Cell envelope: Biosynthesis and degradation of murein sacculus and peptidoglycan
IDP05305
(
show subtarget assignments
)
1
cloned
CD2986
126700607
bacA2
undecaprenyl pyrophosphate phosphatase [...
283
essential/virulence/pathogenesis /
Targets showing phylogenetic evidence for essentiality, virulence or pathogenesi...
Phase 5: 2010
Clostridium difficile
Cell envelope: Biosynthesis and degradation of murein sacculus and peptidoglycan
IDP05289
(
show subtarget assignments
)
1
soluble
CD0784
126698364
putative N-acetylmuramoyl-L-alanine amid...
281
essential/virulence/pathogenesis /
Targets showing phylogenetic evidence for essentiality, virulence or pathogenesi...
Phase 5: 2010
Clostridium difficile
Cell envelope: Biosynthesis and degradation of murein sacculus and peptidoglycan
IDP05248
(
show subtarget assignments
)
1
cloned
lmo2691
16804728
-
autolysin [Listeria monocytogenes EGD-e]...
590
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
3FI7
16.1%
Listeria monocytogenes
Cell envelope: Biosynthesis and degradation of murein sacculus and peptidoglycan
IDP05232
(
show subtarget assignments
)
1
in_pdb
3TX1
lmo1420
16803460
-
hypothetical protein lmo1420 [Listeria m...
298
potential drug target /
Known drug target or ortholog of known drug target
Phase 5: 2010
3TX1
100%
Listeria monocytogenes
Cell envelope: Biosynthesis and degradation of murein sacculus and peptidoglycan
IDP05225
(
show subtarget assignments
)
1
cloned
lmo0415
16802459
-
hypothetical protein lmo0415 [Listeria m...
466
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
2C1G
29%
Listeria monocytogenes
Cell envelope: Biosynthesis and degradation of murein sacculus and peptidoglycan
IDP05244
(
show subtarget assignments
)
1
soluble
lmo2203
16804242
-
hypothetical protein lmo2203 [Listeria m...
367
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
1M9S
22.6%
Listeria monocytogenes
Cell envelope: Biosynthesis and degradation of murein sacculus and peptidoglycan
IDP05124
(
show subtarget assignments
)
1
soluble
BA_3893
30258407
putative cell wall hydrolase [Bacillus a...
265
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Bacillus anthracis
Cell envelope: Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides
IDP91282
(
show subtarget assignments
)
8
selected
NT05BA5499
49182184
glycosyl transferase, WecB/TagA/CpsF fam...
246
potential drug target /
These targets are similar to actual drug targets and will be used mostly for coc...
Community Requests
Bacillus anthracis
Cell envelope: Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides
IDP91088
(
show subtarget assignments
)
8
cloned
BMA_2275
52429282
kdsB
3-deoxy-D-manno-octulosonate cytidylyltr...
263
potential drug target /
KDO is an essential component of the lipopolysaccharide (LPS) layer. Cells defec...
Community Requests
3K8D
52.1%
Burkholderia mallei
Cell envelope: Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides
IDP05111
(
show subtarget assignments
)
1
cloned
CD2187
126699803
putative phage-related cell wall hydrola...
297
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
3FI7
21.2%
Clostridium difficile
Cell envelope: Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides
IDP05739
(
show subtarget assignments
)
1
cloned
CD2136
126699752
uppS
undecaprenyl pyrophosphate synthetase [C...
244
essential/virulence/pathogenesis /
Targets showing phylogenetic evidence for essentiality, virulence or pathogenesi...
Phase 5: 2010
1F75
52.9%
Clostridium difficile
Cell envelope: Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides
IDP05731
(
show subtarget assignments
)
1
cloned
CD1033
126698617
mnaA
UDP-N-acetylglucosamine 2-epimerase [Clo...
374
essential/virulence/pathogenesis /
Targets showing phylogenetic evidence for essentiality, virulence or pathogenesi...
Phase 5: 2010
1O6C
60.4%
Clostridium difficile
Cell envelope: Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides
IDP05623
(
show subtarget assignments
)
1
expressed
CD1034
126698618
putative mannosyl-glycoprotein endo-beta...
324
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
3FI7
17.3%
Clostridium difficile
Cell envelope: Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides
IDP05550
(
show subtarget assignments
)
1
cloned
lmo0481
16802524
-
hypothetical protein lmo0481 [Listeria m...
566
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Listeria monocytogenes
Cell envelope: Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides
IDP05531
(
show subtarget assignments
)
1
cloned
CD2770
126700386
putative capsular polysaccharide biosynt...
363
essential/virulence/pathogenesis /
Targets showing phylogenetic evidence for essentiality, virulence or pathogenesi...
Phase 5: 2010
3C48
25.3%
Clostridium difficile
Cell envelope: Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides
IDP05510
(
show subtarget assignments
)
1
soluble
CD1303
126698901
NAD-dependent deacetylase [Clostridium d...
245
essential/virulence/pathogenesis /
Targets showing phylogenetic evidence for essentiality, virulence or pathogenesi...
Phase 5: 2010
1MA3
40.8%
Clostridium difficile
Cell envelope: Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides
IDP05351
(
show subtarget assignments
)
1
cloned
CD1522
126699126
putative polysaccharide deacetylase [Clo...
293
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
2W3Z
33%
Clostridium difficile
Cell envelope: Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides
IDP05324
(
show subtarget assignments
)
1
cloned
CD3431
126701054
putative cobalamin biosynthesis kinase [...
295
essential/virulence/pathogenesis /
Targets showing phylogenetic evidence for essentiality, virulence or pathogenesi...
Phase 5: 2010
1VIS
24.7%
Clostridium difficile
Cell envelope: Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides
IDP05261
(
show subtarget assignments
)
1
cloned
CD2772
126700388
tuaG
putative teichuronic acid biosynthesis g...
212
essential/virulence/pathogenesis /
Targets showing phylogenetic evidence for essentiality, virulence or pathogenesi...
Phase 5: 2010
3BCV
23.6%
Clostridium difficile
Cell envelope: Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides
IDP05258
(
show subtarget assignments
)
1
cloned
CD2761
126700377
putative N-acetylmuramoyl-L-alanine amid...
301
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
1JWQ
23.9%
Clostridium difficile
Cell envelope: Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides
IDP05247
(
show subtarget assignments
)
1
cloned
lmo2636
16804674
-
hypothetical protein lmo2636 [Listeria m...
360
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
1VRM
29.4%
Listeria monocytogenes
Cell envelope: Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides
IDP05194
(
show subtarget assignments
)
1
cloned
CD0843
126698423
putative glycosyl transferase [Clostridi...
411
essential/virulence/pathogenesis /
Targets showing phylogenetic evidence for essentiality, virulence or pathogenesi...
Phase 5: 2010
2JJM
19.2%
Clostridium difficile
Cell envelope: Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides
IDP05213
(
show subtarget assignments
)
1
cloned
CD2769
126700385
capsular polysaccharide biosynthesis pro...
597
essential/virulence/pathogenesis /
Targets showing phylogenetic evidence for essentiality, virulence or pathogenesi...
Phase 5: 2010
2GN4
17.4%
Clostridium difficile
Cell envelope: Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides
IDP02275
(
show subtarget assignments
)
1
cloned
FTT1158c
56708229
Type IV pili glycosylation protein [Fran...
198
Conserved; Drug target functions; Drug target motif
Phase 3: June 2008
Francisella tularensis
Cell envelopeCellular processes
Surface structuresPathogenesis,Cell adhesion
IDP02679
(
show subtarget assignments
)
1
cloned
FTT0889c
56707990
Type IV pili fiber building block protei...
146
Drug Target
Phase 3: June 2008
3SOJ
76.7%
Francisella tularensis
Cell envelopeCellular processes
Surface structuresPathogenesis
IDP02240
(
show subtarget assignments
)
1
cloned
FTT1572c
56708598
ompH
outer membrane protein OmpH [Francisella...
167
Drug Target
Phase 3: June 2008
1SG2
23.4%
Francisella tularensis
Cell envelopeMobile and extrachromosomal element functions
OtherProphage functions
IDP05148
(
show subtarget assignments
)
1
soluble
BA_0177
30253685
putative lipoprotein [Bacillus anthracis...
254
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Bacillus anthracis
Cell envelope: Other
IDP05151
(
show subtarget assignments
)
1
purified
BA_0307
30253847
putative lipoprotein [Bacillus anthracis...
397
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
2QX2
29%
Bacillus anthracis
Cell envelope: Other
IDP05109
(
show subtarget assignments
)
1
cloned
CD1987
126699595
cell surface protein [Clostridium diffic...
478
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Clostridium difficile
Cell envelope: Other
IDP05104
(
show subtarget assignments
)
1
cloned
CD1233
126698829
cell surface protein [Clostridium diffic...
475
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Clostridium difficile
Cell envelope: Other
IDP05089
(
show subtarget assignments
)
1
cloned
BA_4065
30258571
putative prophage LambdaBa02, lipoprotei...
198
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Bacillus anthracis
Cell envelope: Other
IDP05092
(
show subtarget assignments
)
1
cloned
CD1047
126698631
cell surface protein [Clostridium diffic...
350
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Clostridium difficile
Cell envelope: Other
IDP05726
(
show subtarget assignments
)
1
soluble
BA_3927
30258439
lipoprotein, Bmp family [Bacillus anthra...
355
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
2FQW
37.7%
Bacillus anthracis
Cell envelope: Other
IDP05718
(
show subtarget assignments
)
1
expressed
BA_1601
30255901
putative lipoprotein [Bacillus anthracis...
103
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Bacillus anthracis
Cell envelope: Other
IDP05098
(
show subtarget assignments
)
1
soluble
CD0569
126698147
putative outer membrane lipoprotein [Clo...
334
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
2FQW
21.3%
Clostridium difficile
Cell envelope: Other
IDP05745
(
show subtarget assignments
)
1
cloned
CD2787
126700403
cwp84
cell surface protein (putative cell surf...
803
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
1FH0
8.2%
Clostridium difficile
Cell envelope: Other
IDP05106
(
show subtarget assignments
)
1
cloned
CD1469
126699073
cell surface protein (putative penicilli...
990
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
2QMI
10%
Clostridium difficile
Cell envelope: Other
IDP05088
(
show subtarget assignments
)
1
cloned
BA_0871
30254621
LPXTG-motif cell wall anchor domain prot...
969
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
3KPT
10.8%
Bacillus anthracis
Cell envelope: Other
IDP05655
(
show subtarget assignments
)
1
soluble
lmo0159
16802207
-
peptidoglycan binding protein [Listeria ...
793
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
3KPT
14.4%
Listeria monocytogenes
Cell envelope: Other
IDP05640
(
show subtarget assignments
)
1
cloned
CD2767
126700383
cell surface protein [Clostridium diffic...
703
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Clostridium difficile
Cell envelope: Other
IDP05641
(
show subtarget assignments
)
1
soluble
CD2799
126700415
cell surface protein [Clostridium diffic...
631
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Clostridium difficile
Cell envelope: Other
IDP05637
(
show subtarget assignments
)
1
cloned
CD2518
126700135
cell surface protein [Clostridium diffic...
456
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Clostridium difficile
Cell envelope: Other
IDP05639
(
show subtarget assignments
)
1
soluble
CD2713
126700327
cell surface protein [Clostridium diffic...
653
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
2V04
14.4%
Clostridium difficile
Cell envelope: Other
IDP05629
(
show subtarget assignments
)
1
cloned
CD1803
126699412
cell surface protein [Clostridium diffic...
581
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Clostridium difficile
Cell envelope: Other
IDP05635
(
show subtarget assignments
)
1
cloned
CD2193
126699809
cell surface protein [Clostridium diffic...
480
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Clostridium difficile
Cell envelope: Other
IDP05625
(
show subtarget assignments
)
1
soluble
CD1348
126698947
putative lipoprotein [Clostridium diffic...
178
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Clostridium difficile
Cell envelope: Other
IDP05617
(
show subtarget assignments
)
1
cloned
CD0440
126698013
cell surface protein [Clostridium diffic...
386
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Clostridium difficile
Cell envelope: Other
IDP05618
(
show subtarget assignments
)
1
cloned
CD0514
126698095
cell surface protein (putative hemagglut...
1630
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Clostridium difficile
Cell envelope: Other
IDP05620
(
show subtarget assignments
)
1
cloned
CD0738
126698318
hypothetical protein CD0738 [Clostridium...
293
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Clostridium difficile
Cell envelope: Other
IDP05614
(
show subtarget assignments
)
1
soluble
BA_5326
30259802
putative lipoprotein [Bacillus anthracis...
321
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Bacillus anthracis
Cell envelope: Other
IDP05612
(
show subtarget assignments
)
1
soluble
BA_5233
30259713
putative lipoprotein [Bacillus anthracis...
129
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Bacillus anthracis
Cell envelope: Other
IDP05610
(
show subtarget assignments
)
1
soluble
BA_5062
30259551
putative lipoprotein [Bacillus anthracis...
192
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Bacillus anthracis
Cell envelope: Other
IDP05615
(
show subtarget assignments
)
1
soluble
BA_5522
30259982
putative lipoprotein [Bacillus anthracis...
126
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Bacillus anthracis
Cell envelope: Other
IDP05596
(
show subtarget assignments
)
1
cloned
BA_3366
30257909
putative lipoprotein [Bacillus anthracis...
278
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Bacillus anthracis
Cell envelope: Other
IDP05592
(
show subtarget assignments
)
1
cloned
BA_3194
30257761
putative lipoprotein [Bacillus anthracis...
160
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Bacillus anthracis
Cell envelope: Other
IDP05590
(
show subtarget assignments
)
1
soluble
BA_2986
30257575
putative lipoprotein [Bacillus anthracis...
189
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Bacillus anthracis
Cell envelope: Other
IDP05588
(
show subtarget assignments
)
1
cloned
BA_2883
30257480
putative lipoprotein [Bacillus anthracis...
214
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Bacillus anthracis
Cell envelope: Other
IDP05589
(
show subtarget assignments
)
1
soluble
BA_2931
30257523
putative lipoprotein [Bacillus anthracis...
149
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Bacillus anthracis
Cell envelope: Other
IDP05582
(
show subtarget assignments
)
1
cloned
BA_1978
30256633
putative lipoprotein [Bacillus anthracis...
218
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Bacillus anthracis
Cell envelope: Other
IDP05586
(
show subtarget assignments
)
1
expressed
BA_2746
30257351
putative lipoprotein [Bacillus anthracis...
198
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Bacillus anthracis
Cell envelope: Other
IDP05607
(
show subtarget assignments
)
1
cloned
BA_4862
30259361
putative lipoprotein [Bacillus anthracis...
123
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
2JQO
23.6%
Bacillus anthracis
Cell envelope: Other
IDP05580
(
show subtarget assignments
)
1
soluble
BA_0936
30254679
putative lipoprotein [Bacillus anthracis...
138
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Bacillus anthracis
Cell envelope: Other
IDP05567
(
show subtarget assignments
)
1
cloned
lmo2576
16804614
-
pepdidoglycan bound protein [Listeria mo...
1530
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
3KPT
7.5%
Listeria monocytogenes
Cell envelope: Other
IDP05683
(
show subtarget assignments
)
1
cloned
lmo1379
16803419
-
OxaA-like protein precursor [Listeria mo...
275
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Listeria monocytogenes
Cell envelope: Other
IDP05107
(
show subtarget assignments
)
1
cloned
CD1751
126699358
cell surface protein (putative cell surf...
795
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
1VSN
8.4%
Clostridium difficile
Cell envelope: Other
IDP05555
(
show subtarget assignments
)
1
cloned
lmo1413
16803453
-
peptidoglycan binding protein [Listeria ...
439
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
2KVZ
6.2%
Listeria monocytogenes
Cell envelope: Other
IDP05577
(
show subtarget assignments
)
1
soluble
BA_0602
30254206
putative lipoprotein [Bacillus anthracis...
172
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Bacillus anthracis
Cell envelope: Other
IDP05532
(
show subtarget assignments
)
1
soluble
CD2784
126700400
cell surface protein [Clostridium diffic...
675
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
3NE8
9.6%
Clostridium difficile
Cell envelope: Other
IDP05069
(
show subtarget assignments
)
1
cloned
CD2789
126700405
cwp66
cell surface protein [Clostridium diffic...
610
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Clostridium difficile
Cell envelope: Other
IDP05068
(
show subtarget assignments
)
1
soluble
CD2735
126700350
cell surface protein [Clostridium diffic...
475
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
2KQ8
5.5%
Clostridium difficile
Cell envelope: Other
IDP05515
(
show subtarget assignments
)
1
cloned
CD1687
126699293
putative lipoprotein [Clostridium diffic...
278
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Clostridium difficile
Cell envelope: Other
IDP05511
(
show subtarget assignments
)
1
cloned
BA_5634
30260085
putative lipoprotein [Bacillus anthracis...
196
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Bacillus anthracis
Cell envelope: Other
IDP05507
(
show subtarget assignments
)
1
cloned
BA_5374
30259847
putative lipoprotein [Bacillus anthracis...
161
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Bacillus anthracis
Cell envelope: Other
IDP05508
(
show subtarget assignments
)
1
cloned
BA_5398
30259871
putative lipoprotein [Bacillus anthracis...
143
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Bacillus anthracis
Cell envelope: Other
IDP05521
(
show subtarget assignments
)
1
cloned
CD1858
126699468
putative cell surface protein [Clostridi...
526
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Clostridium difficile
Cell envelope: Other
IDP05503
(
show subtarget assignments
)
1
cloned
BA_4863
30259362
putative lipoprotein [Bacillus anthracis...
124
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Bacillus anthracis
Cell envelope: Other
IDP05472
(
show subtarget assignments
)
1
cloned
BA_2584
30257206
putative lipoprotein [Bacillus anthracis...
197
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Bacillus anthracis
Cell envelope: Other
IDP05476
(
show subtarget assignments
)
1
soluble
BA_2745
30257350
putative lipoprotein [Bacillus anthracis...
117
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Bacillus anthracis
Cell envelope: Other
IDP05478
(
show subtarget assignments
)
1
cloned
BA_2933
30257525
putative lipoprotein [Bacillus anthracis...
203
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Bacillus anthracis
Cell envelope: Other
IDP05469
(
show subtarget assignments
)
1
expressed
BA_2398
30257029
putative lipoprotein [Bacillus anthracis...
177
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Bacillus anthracis
Cell envelope: Other
IDP05460
(
show subtarget assignments
)
1
cloned
BA_0985
30254723
putative lipoprotein [Bacillus anthracis...
153
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Bacillus anthracis
Cell envelope: Other
IDP05466
(
show subtarget assignments
)
1
soluble
BA_1948
30256606
putative lipoprotein [Bacillus anthracis...
148
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Bacillus anthracis
Cell envelope: Other
IDP05483
(
show subtarget assignments
)
1
soluble
BA_3005
30257593
putative lipoprotein [Bacillus anthracis...
128
associated with virulence and/or pathogenesis; vaccine candidate
Phase 5: 2010
Bacillus anthracis
Cell envelope: Other
previous
|
9
|
10
|
11
|
12
|
13
|
14
|
15
|
16
|
17
|
18
|
19
|
20
|
21
|
22
|
23
|
24
|
25
|
26
|
27
|
next
Filter Columns
Filter Columns:
Target Id
Locus Tag
Priority
Stage
Ncbi Gi
Gene Name
Common Name
Length
Justification
Project
Homolog Pdb Id
Homolog Sequence Identity
Organism
Tigr Main Role
Tigr Sub Role
